Stocks · Health care · Pharmaceutical Preparations

UroGen Pharma Ltd.

URGN Clue Score39
Israel Fiscal year ends December CIK 0001668243 Results filed 4 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Mark Schoenberg
18 Nov 2021
Chief Medical Officer
Buy
160
$13.10
$2.10K
Jason Drew Smith
17 May 2021
General Counsel
Buy
2,500
$15.71
$39.28K
Molly Henderson
17 May 2021
Chief Financial Officer
Buy
2,500
$15.85
$39.63K
Elizabeth A. Barrett
14 Dec 2020
Chief Executive Officer
Buy
10,000
$18.50
$185.00K
Elizabeth A. Barrett
21 Nov 2019
Chief Executive Officer
Buy
7,530
$28.00
$210.84K
Elizabeth A. Barrett
20 Nov 2019
Chief Executive Officer
Buy
7,470
$28.00
$209.16K
Mark Schoenberg
19 Nov 2019
Chief Medical Officer
Buy indirect
1,960
$28.17
$55.21K
Elizabeth A. Barrett
15 Nov 2019
Chief Executive Officer
Buy
1,548
$26.00
$40.25K
Mark Schoenberg
21 Mar 2019
Chief Medical Officer
Buy
272
$37.01
$10.07K

What was left out

Form 4 filings counted 196
Amendments (4/A) skipped 12
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 4
Sales straight out of an exercise 60
Sales at will 31
Transactions with no price 0
Shares from compensation/vesting 1,178,534
Sales filed before the plan box existed 17
History held since 29 Nov 2017